An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients
Condition: Hepatitis CInterventions: Drug: Telaprevir; Drug: ribavirin; Drug: peginterferon alfa-2aSponsor: Vertex Pharmaceuticals IncorporatedActive, not recruiting - verified February 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Incivek | Liver | Liver Transplant | Research | Study | Transplant Surgery | Transplants | Urology & Nephrology